Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

China BCT Pharmacy Group, Inc. (CNBI) Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08
Revenues241.9257.5200.8136.1109.0
            Revenue growth-6.1%28.2%47.6%24.9% 
Cost of goods sold193.2195.7152.0100.679.4
Gross profit48.761.848.835.529.6
            Gross margin20.1%24.0%24.3%26.1%27.2%
Sales and marketing7.67.25.43.92.1
Research and development   0.10.8
General and administrative11.712.48.14.63.3
EBITA29.542.335.426.923.4
            EBITA margin12.2%16.4%17.6%19.8%21.5%
Amortization of intangibles0.10.1   
EBIT29.442.235.426.923.4
            EBIT margin12.2%16.4%17.6%19.8%21.5%
Pre-tax income28.542.234.825.722.3
Income taxes7.511.09.16.30.0
            Tax rate26.2%26.1%26.1%24.4%0.0%
Earnings from continuing ops-5.1-3.925.719.4 
Earnings from discontinued ops21.131.2   
Net income16.027.325.719.40.0
            Net margin6.6%10.6%12.8%14.3%0.0%
 
Diluted EPS($0.13)($0.10)$0.67  
Shares outstanding (diluted)38.238.238.3  
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy